FIELD: medicine, oncology, immunology. SUBSTANCE: method involves the use of immunostimulating agents in combination with anticoagulants and fibrinolytics. Method can be used for adjuvant immunotherapy of cancer patients. EFFECT: enhanced effectiveness of immunotherapy. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ENDOMETRIUM CANCER | 1992 |
|
RU2110994C1 |
| METHOD FOR TREATING ENDOMETRIAL CANCER | 1999 |
|
RU2191554C2 |
| AGENT FOR USING AT COMPLEX TREATMENT OF PATIENTS WITH UTERUS AND LUNG CANCER | 1992 |
|
RU2092186C1 |
| METHOD FOR PRODUCING AND APPLYING EMBRYONIC ANTITUMOR MODULATOR AGENT | 2002 |
|
RU2240810C2 |
| NONSPECIFIC IMMUNOTHERAPY AGENT | 2007 |
|
RU2341272C1 |
| AGENT OF ANTIMETASTATIC ACTION | 2007 |
|
RU2341271C1 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| METHOD FOR TREATING THE CASES OF URINARY BLADDER CANCER | 2005 |
|
RU2276605C1 |
| METHOD OF TREATING OVARIAN CANCER, VERSIONS OF ITS METASTASIS AND RECURRENCE | 2015 |
|
RU2582939C1 |
| METHOD FOR PERSONALISING TREATMENT OF YOUNG PATIENTS SUFFERING ENDOMETRIAL CANCER | 2011 |
|
RU2508550C2 |
